应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
PODD 银休特
休市中 12-12 16:00:00 EST
295.70
+1.53
+0.52%
盘后
295.70
+0.00
0.00%
17:53 EST
最高
297.48
最低
293.51
成交量
57.66万
今开
296.08
昨收
294.17
日振幅
1.35%
总市值
208.02亿
流通市值
207.22亿
总股本
7,035万
成交额
1.70亿
换手率
0.82%
流通股本
7,008万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
银休特宣布Omnipod® 5算法增强通过FDA 510(K)清关,重新定义胰岛素输送并简化Pod体验
美股速递 · 12-04
银休特宣布Omnipod® 5算法增强通过FDA 510(K)清关,重新定义胰岛素输送并简化Pod体验
银休特盘中异动 股价大涨5.02%
市场透视 · 11-22
银休特盘中异动 股价大涨5.02%
异动解读 | 银休特季度业绩超预期,股价却盘中大跌5.11%
异动解读 · 11-07
异动解读 | 银休特季度业绩超预期,股价却盘中大跌5.11%
异动解读 | 银休特盘中大涨5.25%,季度业绩超预期且上调全年指引
异动解读 · 11-06
异动解读 | 银休特盘中大涨5.25%,季度业绩超预期且上调全年指引
美股财报 | 银休特发布Q2财报 前半年累计净利润同比减少75.89%
同花顺iNews · 08-08
美股财报 | 银休特发布Q2财报 前半年累计净利润同比减少75.89%
银休特涨11.83% 股价突破300美元大关
市场透视 · 08-07
银休特涨11.83% 股价突破300美元大关
异动解读 | 银休特股价盘前大涨6.33%,创新糖尿病技术演示提振投资者信心
异动解读 · 08-07
异动解读 | 银休特股价盘前大涨6.33%,创新糖尿病技术演示提振投资者信心
银休特涨2.92% 股价突破300美元大关
市场透视 · 07-31
银休特涨2.92% 股价突破300美元大关
银休特跌0.45% 股价跌破300美元大关
市场透视 · 07-07
银休特跌0.45% 股价跌破300美元大关
银休特跌4.51% 股价跌破300美元大关
市场透视 · 07-01
银休特跌4.51% 股价跌破300美元大关
银休特跌1.45% 股价跌破300美元大关
市场透视 · 06-18
银休特跌1.45% 股价跌破300美元大关
Insulet(PODD.US)获Truist Securities首次覆盖,给予买入评级, 目标价365.00美元。
金融界 · 06-17
Insulet(PODD.US)获Truist Securities首次覆盖,给予买入评级, 目标价365.00美元。
银休特盘中异动 早盘大幅跳水5.00%报239.22美元
市场透视 · 03-10
银休特盘中异动 早盘大幅跳水5.00%报239.22美元
银休特盘中异动 大幅跳水5.17%报268.83美元
市场透视 · 02-25
银休特盘中异动 大幅跳水5.17%报268.83美元
银休特2024财年实现净利润4.18亿美元,同比增加102.91%
市场透视 · 02-24
银休特2024财年实现净利润4.18亿美元,同比增加102.91%
花旗:维持Insulet(PODD.US)评级,由买入调整至买入评级, 目标价由310.00美元调整至355.00美元。
金融界 · 02-22
花旗:维持Insulet(PODD.US)评级,由买入调整至买入评级, 目标价由310.00美元调整至355.00美元。
雷蒙德詹姆斯公司:重申Insulet(PODD.US)评级,由优于大市调整至优于大市评级, 目标价由294.00美元调整至328.00美元。
金融界 · 02-22
雷蒙德詹姆斯公司:重申Insulet(PODD.US)评级,由优于大市调整至优于大市评级, 目标价由294.00美元调整至328.00美元。
Stifel:维持Insulet(PODD.US)评级,由持有调整至持有评级, 目标价由245.00美元调整至293.00美元。
金融界 · 02-21
Stifel:维持Insulet(PODD.US)评级,由持有调整至持有评级, 目标价由245.00美元调整至293.00美元。
加拿大投资银行集团:维持Insulet(PODD.US)评级,由买入调整至买入评级, 目标价由304.00美元调整至324.00美元。
金融界 · 02-21
加拿大投资银行集团:维持Insulet(PODD.US)评级,由买入调整至买入评级, 目标价由304.00美元调整至324.00美元。
Insulet 2024年第四季度调整后每股收益 $1.15 超预期 $1.02,营收 $597.50M 超预期 $582.81M
财报速递 · 02-21
Insulet 2024年第四季度调整后每股收益 $1.15 超预期 $1.02,营收 $597.50M 超预期 $582.81M
暂无数据
公司概况
公司名称:
银休特
所属市场:
NASDAQ
上市日期:
--
主营业务:
Insulet Corporation是于2000年成立的一家特拉华州的公司。该公司主要从事开发、制造和销售其专有的胰岛素持续递送系统,用于胰岛素依赖型糖尿病患者。Omnipod平台包括:Omnipod 5自动胰岛素输送系统、Omnipod DASH胰岛素管理系统、Omnipod胰岛素管理系统和最新创新产品Omnipod GOTM,于2023年获得美国食品和药物管理局的许可。该公司还为安进生产Pods,用于Neulasta Onpro试剂盒,这是一种用于安进的Neulasta的递送系统,可帮助降低密集化疗后的感染风险。
发行价格:
--
{"stockData":{"symbol":"PODD","market":"US","secType":"STK","nameCN":"银休特","latestPrice":295.7,"timestamp":1765573200000,"preClose":294.17,"halted":0,"volume":576607,"hourTrading":{"tag":"盘后","latestPrice":295.7,"preClose":295.7,"latestTime":"17:53 EST","volume":41881,"amount":12377853.7485,"timestamp":1765579983101},"delay":0,"floatShares":70078499,"shares":70346898,"eps":3.450812,"marketStatus":"休市中","change":1.53,"latestTime":"12-12 16:00:00 EST","open":296.08,"high":297.48,"low":293.51,"amount":170367094.99787998,"amplitude":0.013496,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.450812,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1179201600000,"exchange":"NASDAQ","adjPreClose":294.17,"preHourTrading":{"tag":"盘前","latestPrice":296,"preClose":294.17,"latestTime":"09:24 EST","volume":26,"amount":7804.49982,"timestamp":1765549456479},"postHourTrading":{"tag":"盘后","latestPrice":295.7,"preClose":295.7,"latestTime":"17:53 EST","volume":41881,"amount":12377853.7485,"timestamp":1765579983101},"volumeRatio":0.8216797116968311,"impliedVol":0.328,"impliedVolPercentile":0.148},"requestUrl":"/m/hq/s/PODD/tweets","defaultTab":"tweets","newsList":[{"id":"1109269322","title":"银休特宣布Omnipod® 5算法增强通过FDA 510(K)清关,重新定义胰岛素输送并简化Pod体验","url":"https://stock-news.laohu8.com/highlight/detail?id=1109269322","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109269322?lang=zh_cn&edition=full","pubTime":"2025-12-04 20:01","pubTimestamp":1764849674,"startTime":"0","endTime":"0","summary":"银休特宣布Omnipod® 5算法增强通过FDA 510(K)清关,重新定义胰岛素输送并简化Pod体验","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","LU2065169927.USD","LU2065170008.USD","LU1119994496.HKD","LU1084165304.USD","LU0728928796.USD","BK4588","LU2324357040.USD","PODD","BK4585","BK4082","LU2065171311.SGD","BK4566","BK4551","LU1261432733.SGD"],"gpt_icon":0},{"id":"2585178074","title":"银休特盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585178074","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585178074?lang=zh_cn&edition=full","pubTime":"2025-11-22 00:52","pubTimestamp":1763743953,"startTime":"0","endTime":"0","summary":"北京时间2025年11月22日00时52分,银休特股票出现波动,股价急速上涨5.02%。银休特股票所在的医疗器械行业中,整体涨幅为2.49%。银休特公司简介:Insulet 成立于2000年,旨在简化糖尿病持续皮下胰岛素输注疗法的使用。其成果是 Omnipod 系统,该系统由一个小型一次性胰岛素输注装置组成,可通过智能手机控制剂量。消息层面,截至00时52分,《瑞士银行上调银休特至买入评级,上调目标价至400美元》资讯为影响银休特的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112200523495130b99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025112200523495130b99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065171402.SGD","BK4566","BK4551","LU1084165304.USD","PODD","BK4588","BK4082","LU2065170008.USD","LU2065171311.SGD","LU2065169927.USD","BK4585","LU2324357040.USD","LU1119994496.HKD","LU1261432733.SGD","LU0728928796.USD"],"gpt_icon":0},{"id":"1171777838","title":"异动解读 | 银休特季度业绩超预期,股价却盘中大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1171777838","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171777838?lang=zh_cn&edition=full","pubTime":"2025-11-07 00:08","pubTimestamp":1762445314,"startTime":"0","endTime":"0","summary":"医疗设备制造商银休特(Insulet Corp,股票代码:PODD)今日盘中大跌5.11%,引发市场关注。这一跌势与公司刚刚公布的强劲季度业绩形成鲜明对比。\n\n根据公司最新发布的财报,银休特第三季度业绩超出华尔街预期。得益于其可穿戴式胰岛素泵的强劲需求,公司总收入同比大幅增长29.9%,达到7.063亿美元,高于分析师预期的6.7673亿美元。调整后每股收益为1.24美元,同样超过预期的1.14美元。\n\n尽管业绩表现亮眼,银休特股价仍出现大幅下跌。这种反差可能暗示了投资者对公司未来发展的担忧,或者市场存在其他未知因素影响。目前,导致股价下跌的具体原因尚不明确,需要进一步观察市场动向。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["PODD"],"gpt_icon":0},{"id":"1172756586","title":"异动解读 | 银休特盘中大涨5.25%,季度业绩超预期且上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1172756586","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172756586?lang=zh_cn&edition=full","pubTime":"2025-11-06 22:51","pubTimestamp":1762440686,"startTime":"0","endTime":"0","summary":"医疗设备制造商银休特今日盘中大涨5.25%,股价表现引人注目。该公司最新公布的第三季度财报超出市场预期,同时上调了全年业绩指引,这些积极因素推动了股价的上涨。根据公司财报,银休特第三季度总收入同比增长29.9%,达到7.063亿美元,超过分析师预期的6.7673亿美元。展望未来,银休特上调了2025年全年业绩指引。其中,Omnipod的年收入增长预期被上调至29%至30%。银休特的业绩表现和未来前景反映了医疗设备行业,特别是糖尿病管理领域的持续增长潜力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["PODD"],"gpt_icon":0},{"id":"2557856709","title":"美股财报 | 银休特发布Q2财报 前半年累计净利润同比减少75.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557856709","media":"同花顺iNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557856709?lang=zh_cn&edition=full","pubTime":"2025-08-08 00:00","pubTimestamp":1754582404,"startTime":"0","endTime":"0","summary":"银休特发布Q2财报,2025财年前六月累计收入12.18亿美元,去年同期累计收入为9.30亿美元,同比增长30.95%。2025财年前六月累计净利润5790.00万美元,去年同期累计净利润为2.40亿美元,同比减少75.89%。公司所属行业为医疗保健设备。该公司主要从事开发、制造和销售其专有的胰岛素持续递送系统,用于胰岛素依赖型糖尿病患者。该公司还为安进生产Pods,用于Neulasta Onpro试剂盒,这是一种用于安进的Neulasta的递送系统,可帮助降低密集化疗后的感染风险。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808000529a47b5c7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808000529a47b5c7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PODD"],"gpt_icon":0},{"id":"2557156165","title":"银休特涨11.83% 股价突破300美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2557156165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557156165?lang=zh_cn&edition=full","pubTime":"2025-08-07 21:32","pubTimestamp":1754573538,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日21时32分,银休特股票出现波动,股价急速拉升11.83%。截至发稿,该股报310.10美元/股,成交量7.4171万股,换手率0.11%,振幅4.62%。银休特股票所在的医疗器械行业中,整体涨幅为1.28%。其相关个股中,Outset Medical, Inc.、Invo Fertility, Inc.、银休特涨幅较大,Invo Fertility, Inc.、Ainos, Inc.、Tenon Medical, Inc.较为活跃,换手率分别为54.46%、10.38%、8.37%,振幅较大的相关个股有Invo Fertility, Inc.、Outset Medical, Inc.、Maxcyte, Inc.,振幅分别为23.98%、13.14%、10.54%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807213230a6d8f9ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807213230a6d8f9ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PODD","BK4082","BK4566","BK4585","LU2065170008.USD","LU2065171402.SGD","LU1084165304.USD","LU0728928796.USD","LU2065169927.USD","BK4588","LU1119994496.HKD","LU2065171311.SGD","LU2324357040.USD","BK4551","LU1261432733.SGD"],"gpt_icon":0},{"id":"1100668499","title":"异动解读 | 银休特股价盘前大涨6.33%,创新糖尿病技术演示提振投资者信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1100668499","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100668499?lang=zh_cn&edition=full","pubTime":"2025-08-07 20:12","pubTimestamp":1754568746,"startTime":"0","endTime":"0","summary":"8月7日周四盘前,糖尿病管理设备制造商银休特股价大涨6.33%,引起市场广泛关注。这一显著涨幅可能与公司近期发布的一份企业演示报告有关。该报告深入展示了银休特旨在改善糖尿病患者生活的创新技术,可能提振了投资者对公司前景的信心。这些积极的客户反馈可能进一步增强了市场对银休特产品的认可度,推动了股价上涨。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["PODD"],"gpt_icon":0},{"id":"2555023034","title":"银休特涨2.92% 股价突破300美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2555023034","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555023034?lang=zh_cn&edition=full","pubTime":"2025-07-31 00:06","pubTimestamp":1753891572,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日00时06分,银休特股票出现异动,股价快速上涨2.92%。截至发稿,该股报300.00美元/股,成交量14.5058万股,换手率0.21%,振幅2.69%。银休特股票所在的医疗器械行业中,整体涨幅为0.37%。银休特公司简介:Insulet成立于2000年,公司的目标是使持续皮下胰岛素输液疗法治疗糖尿病更加容易。自从Omnipod于2005年被美国食品和药物管理局批准以来,全世界大约有500,000名胰岛素依赖型糖尿病患者正在使用其产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073100061297281e8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073100061297281e8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065171311.SGD","BK4082","LU2324357040.USD","PODD","LU0728928796.USD","LU1119994496.HKD","LU1261432733.SGD","LU2065171402.SGD","BK4551","BK4566","LU1084165304.USD","LU2065170008.USD","LU2065169927.USD","BK4585","BK4588"],"gpt_icon":0},{"id":"2549553013","title":"银休特跌0.45% 股价跌破300美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2549553013","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549553013?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:30","pubTimestamp":1751895024,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时30分,银休特股票出现波动,股价大幅下跌0.45%。截至发稿,该股报299.71美元/股,成交量3306股,换手率0.00%,振幅0.00%。银休特股票所在的医疗器械行业中,整体涨幅为0.00%。银休特公司简介:Insulet成立于2000年,公司的目标是使持续皮下胰岛素输液疗法治疗糖尿病更加容易。自从Omnipod于2005年被美国食品和药物管理局批准以来,全世界大约有500,000名胰岛素依赖型糖尿病患者正在使用其产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213024979d16f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213024979d16f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PODD","BK4082","BK4566","BK4585","LU2065170008.USD","LU2065171402.SGD","LU1084165304.USD","LU0728928796.USD","LU2065169927.USD","BK4588","LU1119994496.HKD","LU2065171311.SGD","LU2324357040.USD","BK4551","LU1261432733.SGD"],"gpt_icon":0},{"id":"2548883790","title":"银休特跌4.51% 股价跌破300美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2548883790","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548883790?lang=zh_cn&edition=full","pubTime":"2025-07-01 23:35","pubTimestamp":1751384129,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日23时35分,银休特股票出现异动,股价快速下挫4.51%。截至发稿,该股报300.00美元/股,成交量41.6714万股,换手率0.59%,振幅4.14%。银休特股票所在的医疗器械行业中,整体跌幅为0.12%。银休特公司简介:Insulet成立于2000年,公司的目标是使持续皮下胰岛素输液疗法治疗糖尿病更加容易。自从Omnipod于2005年被美国食品和药物管理局批准以来,全世界大约有500,000名胰岛素依赖型糖尿病患者正在使用其产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507012335309532bad3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507012335309532bad3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4551","LU2065169927.USD","LU0728928796.USD","LU2324357040.USD","LU1119994496.HKD","PODD","LU1084165304.USD","LU1261432733.SGD","LU2065171311.SGD","BK4585","BK4588","LU2065171402.SGD","LU2065170008.USD","BK4082","BK4566"],"gpt_icon":0},{"id":"2544903172","title":"银休特跌1.45% 股价跌破300美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2544903172","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544903172?lang=zh_cn&edition=full","pubTime":"2025-06-18 22:01","pubTimestamp":1750255263,"startTime":"0","endTime":"0","summary":"北京时间2025年06月18日22时01分,银休特股票出现波动,股价急速跳水1.45%。截至发稿,该股报299.99美元/股,成交量2.6344万股,换手率0.04%,振幅1.43%。银休特股票所在的医疗器械行业中,整体跌幅为0.39%。自从Omnipod于2005年被美国食品和药物管理局批准以来,全世界大约有500,000名胰岛素依赖型糖尿病患者正在使用其产品。消息层面,截至22时01分,《储亿银行首予银休特买入评级,目标价365美元》资讯为影响银休特的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506182201039521ea29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506182201039521ea29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2324357040.USD","BK4551","LU2065170008.USD","LU1119994496.HKD","BK4566","LU2065171311.SGD","BK4588","BK4585","LU1084165304.USD","BK4082","LU1261432733.SGD","PODD","LU2065169927.USD","LU0728928796.USD","LU2065171402.SGD"],"gpt_icon":0},{"id":"2544604659","title":"Insulet(PODD.US)获Truist Securities首次覆盖,给予买入评级, 目标价365.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2544604659","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544604659?lang=zh_cn&edition=full","pubTime":"2025-06-17 00:20","pubTimestamp":1750090806,"startTime":"0","endTime":"0","summary":"Insulet(PODD.US)获Truist Securities首次覆盖,给予买入评级, 目标价365.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/17002051100003.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PODD"],"gpt_icon":0},{"id":"2518127466","title":"银休特盘中异动 早盘大幅跳水5.00%报239.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518127466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518127466?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:46","pubTimestamp":1741614369,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时46分,银休特股票出现异动,股价快速下挫5.00%。截至发稿,该股报239.22美元/股,成交量7.0932万股,换手率0.10%,振幅3.93%。银休特股票所在的医疗器械行业中,整体跌幅为0.88%。银休特公司简介:Insulet成立于2000年,公司的目标是使持续皮下胰岛素输液疗法治疗糖尿病更加容易。自从Omnipod于2005年被美国食品和药物管理局批准以来,全世界大约有425,000名胰岛素依赖型糖尿病患者正在使用Omnipod产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214609abf301e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214609abf301e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1084165304.USD","PODD","BK4551","LU0728928796.USD","BK4566","BK4585","BK4082","BK4588","LU2324357040.USD","LU1261432733.SGD","LU1119994496.HKD"],"gpt_icon":0},{"id":"2514138160","title":"银休特盘中异动 大幅跳水5.17%报268.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514138160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514138160?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:04","pubTimestamp":1740495874,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时04分,银休特股票出现波动,股价急速跳水5.17%。截至发稿,该股报268.83美元/股,成交量20.2547万股,换手率0.29%,振幅4.83%。最近的财报数据显示,该股实现营业收入20.72亿美元,净利润4.18亿美元,每股收益5.97美元,毛利14.60亿美元,市盈率46.73倍。机构评级方面,在所有24家参与评级的机构中,83%的券商给予买入建议,17%的券商给予持有建议,无券商给予卖出建议。银休特股票所在的医疗器械行业中,整体跌幅为0.27%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230435abdc865f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230435abdc865f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","PODD","BK4585","BK4566","BK4551","LU1084165304.USD","BK4082","LU0728928796.USD","LU1119994496.HKD","LU1261432733.SGD"],"gpt_icon":0},{"id":"2513756172","title":"银休特2024财年实现净利润4.18亿美元,同比增加102.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513756172","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513756172?lang=zh_cn&edition=full","pubTime":"2025-02-24 00:01","pubTimestamp":1740326473,"startTime":"0","endTime":"0","summary":"2月24日,银休特公布财报,公告显示公司2024财年净利润为4.18亿美元,同比增加102.91%;其中营业收入为20.72亿美元,同比增加22.10%,每股基本收益为5.97美元。从资产负债表来看,银休特总负债18.76亿美元,其中短期债务83.80百万美元,资产负债比为1.65,流动比率为3.59。机构评级:截至2025年2月24日,当前有20家机构对银休特目标价做出预测,其中目标均价为319.85美元,其中最低目标价为280.00美元,最高目标价为355.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000145a250ce19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000145a250ce19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PODD"],"gpt_icon":0},{"id":"2513321565","title":"花旗:维持Insulet(PODD.US)评级,由买入调整至买入评级, 目标价由310.00美元调整至355.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513321565","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513321565?lang=zh_cn&edition=full","pubTime":"2025-02-22 02:01","pubTimestamp":1740160873,"startTime":"0","endTime":"0","summary":"花旗:维持Insulet(PODD.US)评级,由买入调整至买入评级, 目标价由310.00美元调整至355.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/22020148321154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PODD"],"gpt_icon":0},{"id":"2513292240","title":"雷蒙德詹姆斯公司:重申Insulet(PODD.US)评级,由优于大市调整至优于大市评级, 目标价由294.00美元调整至328.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513292240","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513292240?lang=zh_cn&edition=full","pubTime":"2025-02-22 00:05","pubTimestamp":1740153913,"startTime":"0","endTime":"0","summary":"雷蒙德詹姆斯公司:重申Insulet(PODD.US)评级,由优于大市调整至优于大市评级, 目标价由294.00美元调整至328.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/22000548320825.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PODD"],"gpt_icon":0},{"id":"2513299307","title":"Stifel:维持Insulet(PODD.US)评级,由持有调整至持有评级, 目标价由245.00美元调整至293.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513299307","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513299307?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:50","pubTimestamp":1740149454,"startTime":"0","endTime":"0","summary":"Stifel:维持Insulet(PODD.US)评级,由持有调整至持有评级, 目标价由245.00美元调整至293.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/21225048320323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PODD"],"gpt_icon":0},{"id":"2513262260","title":"加拿大投资银行集团:维持Insulet(PODD.US)评级,由买入调整至买入评级, 目标价由304.00美元调整至324.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513262260","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513262260?lang=zh_cn&edition=full","pubTime":"2025-02-21 20:40","pubTimestamp":1740141632,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团:维持Insulet(PODD.US)评级,由买入调整至买入评级, 目标价由304.00美元调整至324.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/21204048318759.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PODD"],"gpt_icon":0},{"id":"1116193338","title":"Insulet 2024年第四季度调整后每股收益 $1.15 超预期 $1.02,营收 $597.50M 超预期 $582.81M","url":"https://stock-news.laohu8.com/highlight/detail?id=1116193338","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116193338?lang=zh_cn&edition=full","pubTime":"2025-02-21 05:04","pubTimestamp":1740085466,"startTime":"0","endTime":"0","summary":"Insulet报告季度每股收益为 $1.15,较分析师一致预期的 $1.02 高出 12.75%。与去年同期每股收益 $1.40 相比下降了 17.86%。以上内容来自Benzinga Earnings专栏,原文如下:Insulet reported quarterly earnings of $1.15 per share which beat the analyst consensus estimate of $1.02 by 12.75 percent. This is a 17.86 percent decrease over earnings of $1.40 per share from the same period last year. The company reported quarterly sales of $597.50 million which beat the analyst consensus estimate of $582.81 million by 2.52 percent. This is a 17.20 percent increase","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Insulet 2024年第四季度调整后每股收益 $1.15 超预期 $1.02,营收 $597.50M 超预期 $582.81M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PODD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.insulet.com","stockEarnings":[{"period":"1week","weight":-0.0289},{"period":"1month","weight":-0.1221},{"period":"3month","weight":-0.1348},{"period":"6month","weight":-0.0293},{"period":"1year","weight":0.0882},{"period":"ytd","weight":0.1326}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Insulet Corporation是于2000年成立的一家特拉华州的公司。该公司主要从事开发、制造和销售其专有的胰岛素持续递送系统,用于胰岛素依赖型糖尿病患者。Omnipod平台包括:Omnipod 5自动胰岛素输送系统、Omnipod DASH胰岛素管理系统、Omnipod胰岛素管理系统和最新创新产品Omnipod GOTM,于2023年获得美国食品和药物管理局的许可。该公司还为安进生产Pods,用于Neulasta Onpro试剂盒,这是一种用于安进的Neulasta的递送系统,可帮助降低密集化疗后的感染风险。","yearOnYearQuotes":[{"month":1,"riseRate":0.611111,"avgChangeRate":-0.000513},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.008002},{"month":3,"riseRate":0.666667,"avgChangeRate":0.008437},{"month":4,"riseRate":0.444444,"avgChangeRate":0.018608},{"month":5,"riseRate":0.444444,"avgChangeRate":0.026797},{"month":6,"riseRate":0.789474,"avgChangeRate":0.048531},{"month":7,"riseRate":0.368421,"avgChangeRate":-0.014587},{"month":8,"riseRate":0.789474,"avgChangeRate":0.073949},{"month":9,"riseRate":0.526316,"avgChangeRate":0.010557},{"month":10,"riseRate":0.526316,"avgChangeRate":-0.010123},{"month":11,"riseRate":0.684211,"avgChangeRate":0.083141},{"month":12,"riseRate":0.421053,"avgChangeRate":0.032552}],"exchange":"NASDAQ","name":"银休特","nameEN":"Insulet"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"银休特(PODD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供银休特(PODD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"银休特,PODD,银休特股票,银休特股票老虎,银休特股票老虎国际,银休特行情,银休特股票行情,银休特股价,银休特股市,银休特股票价格,银休特股票交易,银休特股票购买,银休特股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"银休特(PODD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供银休特(PODD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}